The journals of gerontology. Series A, Biological sciences and medical sciences

Sixth Annual Meeting of the Midwest Aging Research Group

Updated

Abstract

The Sixth Annual Research Symposium of the Midwest Aging Consortium attracted a record number of aging researchers in April 2025.

  • Interdisciplinary research addressed key aging mechanisms such as lipid metabolism and mitochondrial dysfunction.
  • Presentations included new therapeutic concepts and clinical trial approaches related to aging.
  • Cutting-edge methodologies like single-cell transcriptomics and organoid cultures were showcased to study aging.
  • Collaborations among trainees and early career investigators were emphasized as vital for advancing aging research.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

I.S., D.W.L., H.M.B.-B., T.W.R., H.B., R.M.A., and N.K.L serve on the editorial board of the Biological Sciences section of the Journal of Gerontology, Series A. M.J.S. and Mayo Clinic have intellectual property related to senescence research. D.J.B. has a potential financial interest related to this research. He is a co-inventor on patents held by Mayo Clinic, patent applications licensed to or filed by Unity Biotechnology, and a Unity Biotechnology shareholder. Research in both the Schafer and Baker labs is reviewed by the Mayo Clinic Conflict of Interest Review Board and conducted in compliance with Mayo Clinic Conflict of Interest policies. D.W.L. has received funding from, and is a scientific advisory board member of, Aeovian Pharmaceuticals, which seeks to develop novel, selective mTOR inhibitors for the treatment of various diseases. All other authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free